{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:14:54Z","timestamp":1775628894528,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["Z01 BK 04010-11"],"award-info":[{"award-number":["Z01 BK 04010-11"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA Commissioner\u2019s Fellowship"],"award-info":[{"award-number":["FDA Commissioner\u2019s Fellowship"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["Oak Ridge Institute for Science and Education (ORISE fellowship)"],"award-info":[{"award-number":["Oak Ridge Institute for Science and Education (ORISE fellowship)"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181578","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T13:49:33Z","timestamp":1500644973000},"page":"e0181578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens"],"prefix":"10.1371","volume":"12","author":[{"given":"Wendy G.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Zubkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Kachko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-359X","authenticated-orcid":true,"given":"Marian E.","family":"Major","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"HK Mohd","year":"2013","journal-title":"Hepatology"},{"issue":"9859","key":"ref2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"R Lozano","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MOG.0000000000000062","article-title":"Hepatitis C virus therapy in the direct acting antiviral era","volume":"30","author":"ML Shiffman","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1128\/JVI.01094-10","article-title":"Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus","volume":"84","author":"MS Abdel-Hakeem","year":"2010","journal-title":"J Virol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/gutjnl-2011-300515","article-title":"Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection","volume":"61","author":"G Missale","year":"2012","journal-title":"Gut"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"G Missale","year":"1996","journal-title":"J Clin Invest"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses","volume":"188","author":"SA Kalams","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"S Cooper","year":"1999","journal-title":"Immunity"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"R Thimme","year":"2001","journal-title":"J Exp Med"},{"issue":"24","key":"ref10","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1128\/JVI.76.24.12584-12595.2002","article-title":"Broad Specificity of Virus-Specific CD4(+) T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection","volume":"76","author":"CL Day","year":"2002","journal-title":"J Virol"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"F Lechner","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","article-title":"Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes","volume":"175","author":"J Schulze Zur Wiesch","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/gut.2003.037788","article-title":"Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance","volume":"53","author":"E Spada","year":"2004","journal-title":"Gut"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","article-title":"High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection","volume":"127","author":"GM Lauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees","volume":"77","author":"M Nascimbeni","year":"2003","journal-title":"J Virol"},{"issue":"5645","key":"ref16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"A Grakoui","year":"2003","journal-title":"Science"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"NH Shoukry","year":"2003","journal-title":"J Exp Med"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2010.05.077","article-title":"Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins","volume":"139","author":"H Dahari","year":"2010","journal-title":"Gastroenterology"},{"issue":"19","key":"ref19","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.vaccine.2009.02.045","article-title":"T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation","volume":"27","author":"I Zubkova","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/hep.26747","article-title":"Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees","volume":"59","author":"I Zubkova","year":"2014","journal-title":"Hepatology"},{"issue":"8981","key":"ref21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"HM Diepolder","year":"1995","journal-title":"Lancet"},{"issue":"7053","key":"ref22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"DG Bowen","year":"2005","journal-title":"Nature"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"J Bukh","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"ref24","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/cis362","article-title":"Prospects for prophylactic and therapeutic vaccines against hepatitis C virus","volume":"55","author":"SM Feinstone","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"SM Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.it.2011.01.004","article-title":"Cytokines and the inception of CD8 T cell responses","volume":"32","author":"MA Cox","year":"2011","journal-title":"Trends Immunol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jgm.1144","article-title":"Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model","volume":"10","author":"S El-Gogo","year":"2008","journal-title":"J Gene Med"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.21319","article-title":"CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus","volume":"44","author":"M Puig","year":"2006","journal-title":"Hepatology"},{"issue":"20","key":"ref29","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.vaccine.2007.02.054","article-title":"Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model","volume":"25","author":"S El-Gogo","year":"2007","journal-title":"Vaccine"},{"issue":"9316","key":"ref30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"SH Mehta","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"WO Osburn","year":"2010","journal-title":"Gastroenterology"},{"issue":"38","key":"ref32","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"SE Frey","year":"2010","journal-title":"Vaccine"},{"issue":"261","key":"ref33","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"L Swadling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"SM Kaech","year":"2003","journal-title":"Nat Immunol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4049\/jimmunol.1103481","article-title":"Transfer of CD8+ T cell memory using Bcl-2 as a marker","volume":"190","author":"A Dunkle","year":"2013","journal-title":"J Immunol"},{"issue":"23","key":"ref36","doi-asserted-by":"crossref","first-page":"12793","DOI":"10.1128\/JVI.01519-07","article-title":"The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells","volume":"81","author":"AH Hovav","year":"2007","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development","volume":"97","author":"A Volz","year":"2017","journal-title":"Adv Virus Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:26:09Z","timestamp":1540200369000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181578"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]}}}